Keywords: biovitrum, wyeth, extend, refacto, supply, deal, sweden

Biovitrum and Wyeth extend ReFacto supply deal

Article | 17 November 2008

Print This

Sweden's Biovitrum AB has extended the supply agreement for hemophilia A product ReFacto with US drug major Wyeth until December 2015.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in